Dow Up0.11% Nasdaq Up0.50%

Haemonetics Corporation (HAE)

-NYSE
35.69 Up 0.19(0.54%) Aug 29, 4:05PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 29, 2014Mar 30, 2013Mar 31, 2012
Total Revenue 938,509   891,990   727,844  
Cost of Revenue470,144  463,859  358,604  
Gross Profit 468,365   428,131   369,240  
Operating Expenses
Research Development54,200  44,394  36,801  
Selling General and Administrative365,127  323,053  243,681  
Non Recurring1,711  4,247   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 47,327   56,437   88,758  
Income from Continuing Operations
Total Other Income/Expenses Net(10,926)(6,540)740  
Earnings Before Interest And Taxes36,401  49,897  89,498  
Interest Expense -   -   -  
Income Before Tax36,401  49,897  89,498  
Income Tax Expense1,253  11,097  22,612  
Minority Interest -   -   -  
Net Income From Continuing Ops35,148  38,800  66,886  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 35,148   38,800   66,886  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 35,148   38,800   66,886  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.